Parsley Health offers a membership service that pairs patients with physicians and health coaches to diagnose root causes and create long-term lifestyle-based care plans. The sign-up process uses a long survey and a 75-minute initial physician visit; one year of membership includes five annual doctor visits (approximately four hours of doctor–patient time) and five health coach sessions, plus a web portal for medical data and notes. On the heels of its latest funding, Parsley is launching telemedicine products that include diagnostic testing, personalized functional-medicine care, coaching and 365-day-a-year access to care teams. The first diagnostics product, Comprehensive Hormone Care, targets women with PCOS, PMG, fatigue, weight gain, insomnia and anxiety and can be purchased as a one-time analysis or as part of full membership with coaching, re-testing and progress tracking. Telemedicine will initially be available in New York and California, with plans to expand to all 50 states within six months. Parsley Health offers an annual membership ($150/month) that provides patients with extended clinical visits and ongoing coaching to address root causes of chronic, lifestyle-driven disease rather than relying solely on prescriptions. New members complete a detailed intake and receive a 75-minute initial doctor visit, five annual doctor visits, five certified health-coach sessions, and unlimited direct messaging with their doctor. Patients get transparent access to their medical data, doctor notes, individualized health plans, prescriptions when necessary, and specialist referrals. All doctors and health coaches are full‑time Parsley employees, and the company trains clinicians through a functional-medicine clinical fellowship that emphasizes systems-biology and evaluation of thousands of biomarkers. Parsley operates clinics in San Francisco, New York and Los Angeles and reports strong inbound interest from clinicians who want longer visits and a different approach to care.

Total raised

$36M

Funding rounds

2

Latest round

Series B

Latest activity

Oct 2019